Dmitry Balyasny’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Dmitry Balyasny’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-116,200	Closed	-$10.8M	–	3046
2021 Q4	$10.8M	Buy	+116,200	New	+$7.66M	0.04%	612
2018 Q3	–	Sell	-290,000	Closed	-$12.6M	–	2169
2018 Q2	$12.6M	Buy	290,000 +215,000	+287%	+$9.24M	0.06%	418
2018 Q1	$2.96M	Buy	75,000 +25,000	+50%	+$972K	0.01%	879
2017 Q4	$1.7M	Buy	+50,000	New	+$1.42M	0.01%	1183

Dmitry Balyasny's ARNA Position: Q1 2022 in Review

Dmitry Balyasny sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 245,191 shares — an estimated $22.8M sold.

Dmitry Balyasny first reported a position in ARNA in Q4 2016 and held it in 12 quarters. The position peaked at $42.4M in Q1 2018. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Dmitry Balyasny reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Dmitry Balyasny sold 245,191 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $22.8M.
Dmitry Balyasny first reported a position in Arena Pharmaceuticals Inc in Q4 2016 and held it in 12 quarters.
Dmitry Balyasny's Arena Pharmaceuticals Inc position peaked at $42.4M in Q1 2018.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Balyasny Asset Management's 13F filing for Q1 2022, filed 16 May 2022.